首页> 美国卫生研究院文献>Brazilian Journal of Microbiology >Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran
【2h】

Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran

机译:提高伊朗年轻患者中引起尿路感染的大肠杆菌分离株之间的耐药率和ESBL产生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Emerging antimicrobial resistance rates and Extended-spectrum beta-lactamase producing Escherichia coli recovered from urinary tract infections (UTI) is an increasing problem in specific regions, limiting therapeutic options. One hundred E. coli isolates causing UTI in patients with age from 2 months to 12 years admitted at CMC in the period of April 2009 to March 2010 were tested for antibiotic susceptibility using the disk diffusion method. Surprisingly high resistance rates were recorded for E. coli against TMP/SMX (84%), cefalotin (66%), cefuroxime (50%), cefixime (50%) and ceftriaxone (45%). Antimicrobial susceptibility of E. coli isolates was followed by meropenem (98%), amikacin (95%), nitrofurantoin (91%) and gentamicin (68%). Extended spectrum beta-lactamase production, was observed in 32% of community and 42% of nosocomial isolates. The results of this study and numerous observations regarding the increasing resistance to these antibiotics, in several countries, emphasize the need for local population-specific surveillance for guiding empirical therapy for UTI in children.
机译:从尿路感染(UTI)中回收的新兴抗药性耐药率和产生超广谱β-内酰胺酶的大肠杆菌在特定地区日益严重,限制了治疗选择。使用圆盘扩散法对2009年4月至2010年3月在CMC收治的2个月至12岁的100例引起UTI的大肠杆菌分离株的抗生素敏感性进行了测试。大肠杆菌对TMP / SMX(84%),头孢洛汀(66%),头孢呋辛(50%),头孢克肟(50%)和头孢曲松(45%)的耐药率高得令人惊讶。大肠杆菌分离株的抗菌药敏感性依次为美罗培南(98%),丁胺卡那霉素(95%),呋喃妥因(91%)和庆大霉素(68%)。在32%的社区和42%的医院分离株中观察到了广谱的β-内酰胺酶的产生。这项研究的结果以及许多国家对这些抗生素耐药性增加的众多观察结果强调,需要针对当地人群进行特定监测以指导儿童尿路感染的经验治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号